Target Information
MEplace is a London-based nursery group that focuses on early childhood development, emphasizing both mental and physical health. Founded in 2020 by Vlada Bell, the organization is dedicated to nurturing happier and healthier children through an innovative approach that extends beyond traditional nursery offerings. MEplace develops a unique curriculum informed by scientific research in pediatric neuroscience, child development psychology, and language development, enabling them to provide holistic educational experiences.
With a strong emphasis on mental wellness, MEplace engages children in activities such as mindfulness sessions, yoga, music therapy, and nutritious plant-based meals. The nurseries are staffed with highly trained educators holding degrees in psychology and early childhood education, ensuring that every child receives personalized care and attention that aligns with contemporary psychological practices.
Industry Overview
The early childhood education sector in the UK is undergoing significant transformation, particularly as new research highlights the importance of the formative years in a child's development. Despite the growing awareness, a 2022 survey conducted by the Royal Foundation Centre for Early Childhood revealed that only a small fraction of the population understands the critical nature of early years education, particularly the unique developmental needs of children aged 0-5. This gap underscores the increasing demand for child care providers that offer specialized programs.
Childcare plays a vital role in shaping children's development; however, many parents struggle to find options that prioritize both mental and physical well-being. This has led to an expanding market for alternative nursery options that go beyond conventional care methods, merging academic and psychological insights to foster healthier environments.
Investor interest in this sector is rising as more parents seek tailored childcare experiences reflecting their values, especially in a post-pandemic world where mental health has gained prominence. There is a notable shift towards nurseries promoting integrative approaches, embracing elements such as community support, mental health resources, and parenting education.
In this evolving landscape, MEplace's distinct methodology positions it as a trailblazer, ready to capture a growing audience of progressive parents looking for innovative childcare solutions aligned with modern educational practices.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
The recent fundraising round, which raised £1.2 million in seed funding from Active Partners, aims to accelerate MEplace’s expansion throughout London. The investment will enable the nursery group to open additional sites that cater to the increasing demand for holistic early years education. With a proven model that has already garnered praise from parents and a strong oversubscription rate at its existing locations, MEplace is well-positioned for growth.
Additionally, the funds will support the enhancement of educational offerings for parents, including a digital platform that empowers families through valuable resources such as podcasts, articles, and engaging activities. This move emphasizes MEplace’s commitment to impacting child development holistically.
Investor Information
Active Partners, a prominent consumer investor, leads this funding round. The firm has a strong track record of supporting innovative brands, having worked with successful companies like Soho House and Rapha. Their focus on building communities through unique consumer experiences aligns well with MEplace's mission to create nurturing and inclusive environments for children.
Tom Profumo, a Partner at Active Partners, has expressed his enthusiasm for the project. He highlights the increasing demand for childcare options tailored to the individual development needs of children, which MEplace effectively addresses through its differentiated and science-led approach.
View of Dealert
From an investment perspective, MEplace presents a compelling opportunity, particularly given the rising awareness of the critical importance of early childhood development. The early years nursery sector is increasingly recognizing the necessity for integrative care models, making MEplace's unique offerings highly attractive to discerning parents.
The recent funding round not only underscores the confidence investors have in MEplace's approach but also reflects an understanding of consumer trends, positioning the nursery group favorably within a competitive market. Their impressive net promoter score (NPS) of +90 suggests strong parental satisfaction, indicating a solid foundation from which to expand.
The alignment of MEplace's mission with societal shifts towards mental health awareness and developmental psychology showcases its potential for long-term growth. If the nursery group successfully leverages this investment to enhance its offerings and expand its footprint, it is likely to establish itself as a leader in the early years education sector.
Furthermore, with the backing of Active Partners, MEplace is equipped to foster community engagement and further develop its digital resources, ultimately enhancing its impact on child development. Overall, this investment round presents an exciting opportunity that could yield significant returns as MEplace scales its innovative approach and meets the growing demand for quality early years education.
Similar Deals
Venrex, Cur8 Capital, Active Partners, Emerge, Collective Continuum → Niyyah
2023
University of Oxford Innovation Fund III → Bibliotech Education Limited
2023
TRICAPITAL Angels Limited and Scottish Enterprise → Trademylux Limited
2023
Nesta Impact Investments → MEL Science
2021
Midven → The Supply Register
2020
Ananda – Social Venture Fund → Third Space Learning
2015
Cambridge Innovation Capital, SV Health Investors’ Dementia Discovery Fund, M Ventures, Pfizer Ventures → TRIMTECH Therapeutics
2025
ACF Investors → Monument Therapeutics
2025
Active Partners
invested in
MEplace
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $2M